Wolfe Research analyst issues OUTPERFORM recommendation for DIS on August 28, 2026 02:59PM ET. The previous analyst recommendation was Outperform.DIS was trading at $107.745 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current analyst recommendations are : 40 - Buy, 20 - Hold, 4 - Sell recommendations .Historical Analyst RecommendationsLatest 10 recommendationsReport DateAnalyst...
Ramsey El-Assal from Cantor Fitzgerald issued a price target of $88.00 for AFRM on 2026-08-28 13:26:00.The...
Christian Schwab from Craig-Hallum issued a price target of $300.00 for MRVL on 2026-08-28 12:46:54.The adjusted...
from Susquehanna issued a price target of $110.00 for AFRM on 2026-08-28 12:12:00.The adjusted price target...
KeyBanc analyst issues OVERWEIGHT recommendation for MRVL on August 28, 2026 01:20PM ET. The previous analyst...
Ramsey El-Assal from Cantor Fitzgerald issued a price target of $88.00 for AFRM on 2026-08-28 13:26:00.The adjusted price target was set to $88.00.At the time of the announcement, AFRM was...
Christian Schwab from Craig-Hallum issued a price target of $300.00 for MRVL on 2026-08-28 12:46:54.The adjusted price target was set to $300.00.At the time of the announcement, MRVL was trading...
from Susquehanna issued a price target of $110.00 for AFRM on 2026-08-28 12:12:00.The adjusted price target was set to $110.00.At the time of the announcement, AFRM was trading at $84.86.The...
from BMO Capital issued a price target of $101.00 for AFRM on 2026-08-28 12:09:58.The adjusted price target was set to $101.00.At the time of the announcement, AFRM was trading at...
from Oppenheimer issued a price target of $104.00 for AFRM on 2026-08-28 11:43:17.The adjusted price target was set to $104.00.At the time of the announcement, AFRM was trading at $77.49.The...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
Truist Bank has recently announced a strategic partnership with Trovata, a leading provider of bank application programming interfaces (APIs) and enterprise cash management services. The partnership is expected to greatly...
Yesterday, two Exchange-Traded Funds (ETFs) captured the attention of investors due to their unusually high trading volumes. These two highly popular ETFs, the Nasdaq-100 ETF and the bonds ETF, have...
Truist Bank, one of the largest financial institutions in the United States, has announced a strategic partnership with Trovata, a leading provider of bank application programming interfaces (APIs) and enterprise...
Amazon, the retail giant that generates a staggering $540 billion in annual revenue, is scheduled to report its third-quarter earnings on October 26. Despite already gaining over 50% in stock...
Verizon's stock is experiencing a tremendous surge, poised to have its best day in 15 years. The telecom giant exceeded analyst expectations both in terms of revenue and profit margins....
